These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8254949)

  • 1. [Recent progress in the diagnosis and treatment of diabetes insipidus].
    Kawakami S; Honda K; Ishikawa S; Saito T
    Nihon Rinsho; 1993 Oct; 51(10):2737-41. PubMed ID: 8254949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus.
    Mundschenk J; Rittig S; Siggaard C; Hensen J; Lehnert H
    Exp Clin Endocrinol Diabetes; 2001; 109(8):406-9. PubMed ID: 11748489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus.
    Tae HJ; Baek KH; Shim SM; Yoo SJ; Kang MI; Cha BY; Lee KW; Son HY; Kang SK
    Mol Genet Metab; 2005; 86(1-2):307-13. PubMed ID: 16006166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Böni-Schnetzler M; Böni J; Wichmann W; Huisman T; Vallotton MB; Froesch ER
    J Clin Endocrinol Metab; 1996 Jan; 81(1):192-8. PubMed ID: 8550751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.
    Repaske DR; Medlej R; Gültekin EK; Krishnamani MR; Halaby G; Findling JW; Phillips JA
    J Clin Endocrinol Metab; 1997 Jan; 82(1):51-6. PubMed ID: 8989232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilatative uropathy as a manifestation of neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin-II gene.
    Lindenthal V; Mainberger A; Morris-Rosendahl DJ; Löning L; Mayer W; Müller HL
    Klin Padiatr; 2013 Dec; 225(7):407-12. PubMed ID: 24158882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Glu78 of the AVP-NPII gene impairs neurophysin as a carrier protein for arginine vasopressin in a family with neurohypophyseal diabetes insipidus.
    Lee YW; Lee KW; Ryu JW; Mok JO; Ki CS; Park HK; Kim YJ; Kim SJ; Byun DW; Suh KI; Yoo MH; Shin HB; Lee YK; Kim CH
    Ann Clin Lab Sci; 2008; 38(1):12-4. PubMed ID: 18316776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis, aortic stenosis and sudden onset central diabetes insipidus.
    Hensen J; Seufferlein T; Oelkers W
    Exp Clin Endocrinol Diabetes; 1997; 105(4):227-33. PubMed ID: 9285211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
    Mol Genet Metab; 1999 May; 67(1):89-92. PubMed ID: 10329029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
    Tuschy U; Szeszat S; Meinhold J
    Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin II gene.
    de Fost M; van Trotsenburg AS; van Santen HM; Endert E; van den Elzen C; Kamsteeg EJ; Swaab DF; Fliers E
    Eur J Endocrinol; 2011 Jul; 165(1):161-5. PubMed ID: 21498630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II).
    Flück CE; Deladoëy J; Nayak S; Zeller O; Kopp P; Mullis PE
    Eur J Endocrinol; 2001 Oct; 145(4):439-44. PubMed ID: 11581002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
    Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 17. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II.
    Gagliardi PC; Bernasconi S; Repaske DR
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3643-6. PubMed ID: 9360520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes.
    Skordis N; Patsalis PC; Hettinger JA; Kontou M; Herakleous E; Krishnamani MR; Phillips JA
    Horm Res; 2000; 53(5):239-45. PubMed ID: 11150885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.